Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Intangibles (2020 - 2025)

Biofrontera has reported Intangibles over the past 6 years, most recently at $2.6 million for Q4 2025.

  • Quarterly results put Intangibles at $2.6 million for Q4 2025, up 7471.43% from a year ago — trailing twelve months through Dec 2025 was $2.6 million (up 7471.43% YoY), and the annual figure for FY2025 was $2.6 million, up 7471.43%.
  • Intangibles for Q4 2025 was $2.6 million at Biofrontera, up from $22000.0 in the prior quarter.
  • Over the last five years, Intangibles for BFRIW hit a ceiling of $3.6 million in Q3 2021 and a floor of $22000.0 in Q3 2025.
  • Median Intangibles over the past 5 years was $2.6 million (2025), compared with a mean of $2.1 million.
  • Peak annual rise in Intangibles hit 7471.43% in 2025, while the deepest fall reached 98.94% in 2025.
  • Biofrontera's Intangibles stood at $3.4 million in 2021, then fell by 12.12% to $3.0 million in 2022, then decreased by 13.29% to $2.6 million in 2023, then plummeted by 98.67% to $35000.0 in 2024, then skyrocketed by 7471.43% to $2.6 million in 2025.
  • The last three reported values for Intangibles were $2.6 million (Q4 2025), $22000.0 (Q3 2025), and $26000.0 (Q2 2025) per Business Quant data.